Effects of Berries and Berry Fractions on Metabolic Diseases

NCT01860547 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2013-05-22

No results posted yet for this study

Summary

The study hypothesis is that the bioactive compounds of sea buckthorn berries (Hippophaë rhamnoides), their fractions, and bilberries (Vaccinium myrtillus). have positive effects on lipid and carbohydrate metabolism and will thus reduce the risk of developing metabolic diseases.

Conditions

Interventions

DIETARY_SUPPLEMENT

Bilberries

Frozen bilberries, 100 g/d

DIETARY_SUPPLEMENT

Sea buckthorn berry

Dried sea buckthorn berries, 20 g/d

DIETARY_SUPPLEMENT

Sea buckthorn phenolic extract

Ethanol-water extract from sea buckthorn berries, combined with maltodextrin, 14.6 g/d (7.3 g sea buckthorn extract + 7.3 g maltodextrin)

DIETARY_SUPPLEMENT

Sea buckthorn oil

Sea buckthorn oil, 4 g (8 capsules)/d

Sponsors & Collaborators

  • Pakkasmarja

    collaborator OTHER
  • Saarioinen

    collaborator OTHER
  • Kiantama Ltd.

    collaborator UNKNOWN
  • Aromtech Ltd.

    collaborator INDUSTRY
  • Fazer

    collaborator OTHER
  • Satakunta Sea Buckthorn Society

    collaborator UNKNOWN
  • Finnish Berry Powders Ltd.

    collaborator UNKNOWN
  • University of Turku

    lead OTHER

Principal Investigators

  • Jukka-Pekka Suomela, Ph.D. · University of Turku

  • Heikki Kallio, Prof. · University of Turku

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-06-30
Completion
2009-08-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01860547 on ClinicalTrials.gov